CURIS, INC. Share-based Goods and Nonemployee Services Transaction, Expense (Deprecated 2013-01-31)
CURIS, INC. (CRIS) reported Share-based Goods and Nonemployee Services Transaction, Expense (Deprecated 2013-01-31) of $16.24 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionExpense · last filed 2013-05-09
- CURIS, INC. share-based goods and nonemployee services transaction, expense (deprecated 2013-01-31) for the quarter ending 2013-03-31 was $16.24K, a 92.13% decline year-over-year.
- CURIS, INC. share-based goods and nonemployee services transaction, expense (deprecated 2013-01-31) for the quarter ending 2012-12-31 was -$10.79K, a 112.03% decline year-over-year.
- CURIS, INC. share-based goods and nonemployee services transaction, expense (deprecated 2013-01-31) for the quarter ending 2012-09-30 was $14.68K, a 15.24% increase year-over-year.
- CURIS, INC. share-based goods and nonemployee services transaction, expense (deprecated 2013-01-31) for the quarter ending 2012-06-30 was $174.25K, a 1229.71% increase year-over-year.
- CURIS, INC. share-based goods and nonemployee services transaction, expense (deprecated 2013-01-31) for fiscal 2012 was $355.22K, a 172.66% increase from fiscal 2011.
- CURIS, INC. share-based goods and nonemployee services transaction, expense (deprecated 2013-01-31) for fiscal 2011 was $130.28K, a 988.58% increase from fiscal 2010.
- CURIS, INC. share-based goods and nonemployee services transaction, expense (deprecated 2013-01-31) for fiscal 2010 was $11.97K.
| Period end | Share-based Goods and Nonemployee Services Transaction, Expense (Deprecated 2013-01-31) 3 month | Share-based Goods and Nonemployee Services Transaction, Expense (Deprecated 2013-01-31) 6 month | Share-based Goods and Nonemployee Services Transaction, Expense (Deprecated 2013-01-31) 9 month | Share-based Goods and Nonemployee Services Transaction, Expense (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|
| 2013-03-31 | $16.24K 10-Q · filed 2013-05-09 | $5.45K derived: sum of 2 quarters · filed 2013-05-09 | $20.13K derived: sum of 3 quarters · filed 2013-05-09 | $194.38K derived: sum of 4 quarters · filed 2013-05-09 |
| 2012-12-31 | -$10.79K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-13 | $3.89K derived: sum of 2 quarters · filed 2013-03-13 | $178.13K derived: sum of 3 quarters · filed 2013-03-13 | $355.22K 10-K · filed 2013-03-13 |
| 2012-09-30 | $14.68K 10-Q · filed 2012-11-06 | $188.93K derived: sum of 2 quarters · filed 2012-11-06 | $366.01K 10-Q · filed 2012-11-06 | $485.10K derived: sum of 4 quarters · filed 2013-05-09 |
| 2012-06-30 | $174.25K 10-Q · filed 2012-08-09 | $380.69K 10-Q · filed 2012-08-09 | $470.41K derived: sum of 3 quarters · filed 2013-05-09 | $483.15K derived: sum of 4 quarters · filed 2013-05-09 |
| 2012-03-31 | $206.45K 10-Q · filed 2013-05-09 | $296.17K derived: sum of 2 quarters · filed 2013-05-09 | $308.91K derived: sum of 3 quarters · filed 2013-05-09 | $322.01K derived: sum of 4 quarters · filed 2013-05-09 |
| 2011-12-31 | $89.72K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-13 | $102.46K derived: sum of 2 quarters · filed 2013-03-13 | $115.56K derived: sum of 3 quarters · filed 2013-03-13 | $130.28K 10-K · filed 2013-03-13 |
| 2011-09-30 | $12.74K 10-Q · filed 2012-11-06 | $25.84K derived: sum of 2 quarters · filed 2012-11-06 | $40.56K 10-Q · filed 2012-11-06 | |
| 2011-06-30 | $13.10K 10-Q · filed 2012-08-09 | $27.82K 10-Q · filed 2012-08-09 | ||
| 2010-12-31 | $11.97K 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |